Ototoxicity of artemether/lumefantrine in the treatment of falciparum malaria: a randomized trial

BACKGROUND: Due to increasing drug resistance, artemisinin-based combination chemotherapy (ACT) has become the first-line treatment of falciparum malaria in many endemic countries. However, irreversible ototoxicity associated with artemether/lumefantrine (AL) has been reported recently and suggested...

Descripción completa

Detalles Bibliográficos
Autores principales: Gürkov, Robert, Eshetu, Teferi, Miranda, Isabel Barreto, Berens-Riha, Nicole, Mamo, Yoseph, Girma, Tsinuel, Krause, Eike, Schmidt, Michael, Hempel, John-Martin, Löscher, Thomas
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2008
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2559845/
https://www.ncbi.nlm.nih.gov/pubmed/18796142
http://dx.doi.org/10.1186/1475-2875-7-179

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2559845/
https://www.ncbi.nlm.nih.gov/pubmed/18796142
http://dx.doi.org/10.1186/1475-2875-7-179

Ejemplares similares